These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7774914)

  • 21. Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1.
    Rootwelt H; Berger R; Gray G; Kelly DA; Coşkun T; Kvittingen EA
    Am J Hum Genet; 1994 Oct; 55(4):653-8. PubMed ID: 7942842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hereditary tyrosinemia type III].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract]   [Full Text] [Related]  

  • 24. Tyrosinaemia type III: immunochemical studies on 4-hydroxyphenylpyruvic acid dioxygenase and molecular cloning of cDNA for the enzyme.
    Endo F; Awata H; Tanoue A; Eda Y; Matsuda I
    J Inherit Metab Dis; 1991; 14(5):783-6. PubMed ID: 1779624
    [No Abstract]   [Full Text] [Related]  

  • 25. Tissue distribution, intracellular localization and proteolytic processing of rat 4-hydroxyphenylpyruvate dioxygenase.
    Neve S; Aarenstrup L; Tornehave D; Rahbek-Nielsen H; Corydon TJ; Roepstorff P; Kristiansen K
    Cell Biol Int; 2003; 27(8):611-24. PubMed ID: 12867153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I.
    Awata H; Endo F; Tanoue A; Kitano A; Nakano Y; Matsuda I
    Biochim Biophys Acta; 1994 May; 1226(2):168-72. PubMed ID: 8204664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M; St-Louis M; Demers SI; al-Dhalimy M; Leclerc B; Tanguay RM
    N Engl J Med; 1994 Aug; 331(6):353-7. PubMed ID: 8028615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.
    Timmers C; Grompe M
    Hum Mutat; 1996; 7(4):367-9. PubMed ID: 8723690
    [No Abstract]   [Full Text] [Related]  

  • 31. Single-base substitution at the last nucleotide of exon 6 (c.671G>A), resulting in the skipping of exon 6, and exons 6 and 7 in human succinyl-CoA:3-ketoacid CoA transferase (SCOT) gene.
    Yamada K; Fukao T; Zhang G; Sakurai S; Ruiter JP; Wanders RJ; Kondo N
    Mol Genet Metab; 2007 Mar; 90(3):291-7. PubMed ID: 17169596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24-->qter by fluorescence in situ hybridization.
    Stenman G; Röijer E; Rüetschi U; Dellsén A; Rymo L; Lindstedt S
    Cytogenet Cell Genet; 1995; 71(4):374-6. PubMed ID: 8521727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS).
    Zhao D; Tian Y; Li X; Ni M; Zhu X; Jia L
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):563-567. PubMed ID: 32109208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1993; 2(2):85-93. PubMed ID: 8318997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two novel mutations involved in hereditary tyrosinemia type I.
    St-Louis M; Poudrier J; Phaneuf D; Leclerc B; Laframboise R; Tanguay RM
    Hum Mol Genet; 1995 Feb; 4(2):319-20. PubMed ID: 7757089
    [No Abstract]   [Full Text] [Related]  

  • 36. Self-induced correction of the genetic defect in tyrosinemia type I.
    Kvittingen EA; Rootwelt H; Berger R; Brandtzaeg P
    J Clin Invest; 1994 Oct; 94(4):1657-61. PubMed ID: 7929843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosinemia Type III detected via neonatal screening: management and outcome.
    Heylen E; Scherer G; Vincent MF; Marie S; Fischer J; Nassogne MC
    Mol Genet Metab; 2012 Nov; 107(3):605-7. PubMed ID: 23036342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and structural characterization of the human histidase gene (HAL).
    Suchi M; Sano H; Mizuno H; Wada Y
    Genomics; 1995 Sep; 29(1):98-104. PubMed ID: 8530107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
    Berger R; van Faassen H; Smith GP
    Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human 4-hydroxyphenylpyruvate dioxygenase gene (HPD).
    Rüetschi U; Rymo L; Lindstedt S
    Genomics; 1997 Sep; 44(3):292-9. PubMed ID: 9325050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.